SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-053693
Filing Date
2024-05-06
Accepted
2024-05-06 17:19:02
Documents
76
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ttoo-20240331.htm   iXBRL 10-Q 1736987
2 EX-31.1 ttoo-ex31_1.htm EX-31.1 14345
3 EX-31.2 ttoo-ex31_2.htm EX-31.2 14337
4 EX-32.1 ttoo-ex32_1.htm EX-32.1 6852
5 EX-32.2 ttoo-ex32_2.htm EX-32.2 7036
  Complete submission text file 0000950170-24-053693.txt   9331974

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ttoo-20240331.xsd EX-101.SCH 1733116
80 EXTRACTED XBRL INSTANCE DOCUMENT ttoo-20240331_htm.xml XML 1506404
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36571 | Film No.: 24918651
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)